alexa An Open Label Study Of Modified Matrix Type TDDS Of Carvedilol & Hydrochlorothiazide Combination In Healthy Human Volunteers | 14462
ISSN: 2329-6887

Journal of Pharmacovigilance
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

2nd International Conference and Exhibition on Pharmacovigilance & Clinical Trials

Agrawal S. S
Accepted Abstracts: J Pharmacovigilance
DOI: 10.4172/2329-6887.S1.009
Abstract
Carvedilol (CRV) and hydrochlorothiazide (HCTZ) are the first line therapy for the treatment of uncomplicated essential hypertension. A major barrier to management of hypertension is the extent to which patient comply with the treatment regimen. The TDD system is unique and preferred system of delivery which provides nearly constant plasma level of medication over a prolonged period. Present study was designed to compare bioavailability, pharmacokinetic release profiles and adverse drug reaction along with phase I, open label, balanced, randomized, two- treatment, two- period, single- dose & crossover studies of CRV AND HCTZ containing modified transdermal patch with individual marketed oral formulation of same drugs in healthy, adult human subjects under fasting conditions. Pharmacokinetic parameters of patch were found to beCmax (45.127 ng/ml), Tmax (36 h), and AUC (2183.045 ng h/ml) which signified that the modified patch showed higher concentrations, stable drug release and extent of drug absorbed from patch was greater than tablets. Post dose (after transdermal patches application) the marked decrease in blood pressure was recorded. Patch did not affect the biochemical profile of healthy subjects and showed no hypersensitivity during clinical trial, indicating safety in this regard. The results suggested that transdermal drug delivery system of carvedilol and hydrochlorothiazide showed better safety and efficacy than oral treatment for hypertensive patients.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7